Skip to content

Evaluation of the effects of curcumin in people with chronic venous insufficiency

Evaluation of the effects of curcumin in people with chronic venous insufficiency on wound healing

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
IRCT
Registry ID
IRCT20220404054408N1
Enrollment
72
Registered
2022-08-18
Start date
2022-05-22
Completion date
Unknown
Last updated
2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Chronic venous insufficiency. Cardiovascular and cerebrovascular syphilis

Interventions

Intervention 1: Intervention group:These patients are given tablets containing 500 mg of curcumin (C3 complex) from Sami Labs LTD (Bangalore, India) and 5 mg of piperine orally for 6 weeks. Interventi

Sponsors

Mashhad University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
30 Years to 60 Years

Inclusion criteria

Inclusion criteria: Satisfaction with inclusion in the study Having an age range between 30 and 60 years Having chronic venous insufficiency class 3 and above

Exclusion criteria

Exclusion criteria: Having other vascular diseases Having diabetes Having autoimmune diseases

Design outcomes

Primary

MeasureTime frame
Wound healing. Timepoint: 6 weeks. Method of measurement: Wound length and width.;Reduce edema. Timepoint: 6 weeks later. Method of measurement: Clinical examinations by a subspecialty physician and comparison with pre-interference.;Feeling of heaviness and pain. Timepoint: 6 weeks later. Method of measurement: Clinical examinations by a subspecialty physician and comparison with pre-interference.

Secondary

MeasureTime frame
Blood factors blood cell(WBC)PlateletD-dimer, Fibrinogen, Fibrinogen to albumin, ratioNeutrophil toLymphocyte ,Neutrophil, lymphocyte homocysteine. Timepoint: 6 weeks later. Method of measurement: Laboratory techniques such as diagnostic kits.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactShirin Saberianpour

Mashhad University of Medical Sciences

saberianpoursh@mums.ac.ir+98 51 3841 2081

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026